I C U Medical Inc (ICUI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 49,219 | 30,132 | 732 | 16,466 | 19,862 |
| Depreciation Amortization | 101,214 | 50,801 | 206,919 | 155,024 | 102,592 |
| Accounts receivable | -7,562 | -24,145 | 8,876 | 3,943 | 16,691 |
| Accounts payable and accrued liabilities | -4,909 | 20,150 | 6,998 | 23,328 | 14,382 |
| Other Working Capital | -78,439 | -63,940 | -90,044 | -83,200 | -60,990 |
| Other Operating Activity | 59,536 | 25,911 | 46,366 | 3,687 | -29,999 |
| Operating Cash Flow | $119,059 | $38,909 | $179,847 | $119,248 | $62,538 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -29,791 | -11,301 | -79,984 | -63,355 | -34,275 |
| Net Acquisitions | N/A | 2,000 | 211,185 | 211,185 | 209,464 |
| Purchase Sale Intangibles | -3,555 | -1,908 | -8,972 | -7,210 | -4,541 |
| Other Investing Activity | -1,555 | -1,908 | -8,972 | -7,210 | -4,541 |
| Investing Cash Flow | $-31,346 | $-11,209 | $122,229 | $140,620 | $170,648 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 313 | N/A | N/A |
| Debt Repayment | -55,985 | -5,346 | -304,798 | -274,293 | -248,635 |
| Common Stock Issued | 490 | 0 | 6,106 | 5,972 | 5,972 |
| Other Financing Activity | -38,862 | -38,776 | -13,146 | -8,719 | -8,688 |
| Financing Cash Flow | $-94,357 | $-44,122 | $-311,525 | $-277,040 | $-251,351 |
| Exchange Rate Effect | -3,020 | -3,211 | 8,846 | 8,338 | 9,624 |
| Beginning Cash Position | 307,963 | 307,963 | 308,566 | 308,566 | 308,566 |
| End Cash Position | 298,299 | 288,330 | 307,963 | 299,732 | 300,025 |
| Net Cash Flow | $-9,664 | $-19,633 | $-603 | $-8,834 | $-8,541 |
| Free Cash Flow | |||||
| Operating Cash Flow | 119,059 | 38,909 | 179,847 | 119,248 | 62,538 |
| Capital Expenditure | -29,813 | -11,302 | -88,043 | -63,397 | -34,317 |
| Free Cash Flow | 89,246 | 27,607 | 91,804 | 55,851 | 28,221 |